Markt geschlossen -
Andere Börsenplätze
|
% 5 Tage | % 1. Jan. | ||
0.32 USD | -0.16% | -.--% | +14.29% |
08.05. | Crescita Therapeutics Q1 Verlust weitet sich aus, Umsatz steigt | MT |
08.05. | Crescita Therapeutics Inc. meldet Ergebnis für das erste Quartal zum 31. März 2024 | CI |
Performance
1 Tag | -0.16% | ||
3 Monate | -16.88% | ||
6 Monate | +6.67% | ||
Laufendes Jahr | +14.29% | ||
1 Jahr | -35.56% | ||
3 Jahre | -50.68% | ||
5 Jahre | -43.69% |
Volumen
MärkteBasisdaten
Extremkurse
Indikatoren
Sektorenvergleich - Pharmazeutika - Andere
Name | % | % 5 Tage | % 1. Jan. | % 1 Jahr | Kap. | |
---|---|---|---|---|---|---|
-0.16% | -.--% | +14.29% | -35.56% | 6.2 Mio. | ||
-1.50% | +3.41% | +30.38% | +74.94% | 684 Mrd. | ||
+0.07% | +1.16% | +26.51% | +54.70% | 568 Mrd. | ||
+0.04% | +0.43% | -4.36% | -6.76% | 361 Mrd. | ||
-0.13% | +2.00% | +19.30% | +11.03% | 329 Mrd. | ||
+0.22% | -1.86% | +3.73% | +9.24% | 284 Mrd. | ||
+0.31% | +2.66% | +16.70% | +3.00% | 240 Mrd. | ||
+1.97% | +4.94% | +8.78% | +0.41% | 208 Mrd. | ||
+1.26% | +3.59% | -7.93% | -19.66% | 200 Mrd. | ||
-0.87% | -0.37% | +7.68% | +33.14% | 166 Mrd. | ||
-0.60% | +0.72% | -2.71% | -25.01% | 159 Mrd. | ||
+1.23% | +3.32% | +5.09% | -4.53% | 127 Mrd. | ||
+1.07% | +3.81% | +24.09% | +22.40% | 91.83 Mrd. | ||
+0.45% | +2.16% | -12.41% | -33.97% | 91.1 Mrd. | ||
+2.14% | +1.82% | -18.58% | -15.62% | 82.18 Mrd. | ||
+0.37% | +1.58% | +39.67% | +15.65% | 66.22 Mrd. | ||
Durchschnitt | +0.37% | +1.52% | +9.39% | +5.21% | ||
Gewichteter Durchschnitt nach Marktkapitalisierung | +0.01% | +1.40% | +13.56% | +22.61% |
Historische Daten
Datum | Eröffnung | Hoch | Tief | Schlusskurs | Volumen |
---|
Monatliche Veränderungen
Jährliche Veränderungen
2024 | +14.29% | ||
2023 | -41.72% | ||
2022 | -5.37% | ||
2021 | -6.76% | ||
2020 | -27.05% | ||
2019 | +105.87% | ||
2018 | -16.63% | ||
2017 | -50.35% | ||
2016 | -24.66% |
- Börse
- Aktien
- A2AD5R Aktie
- A2AD5R Aktie
- Kurse Crescita Therapeutics Inc.